JP2014506933A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014506933A5 JP2014506933A5 JP2013556883A JP2013556883A JP2014506933A5 JP 2014506933 A5 JP2014506933 A5 JP 2014506933A5 JP 2013556883 A JP2013556883 A JP 2013556883A JP 2013556883 A JP2013556883 A JP 2013556883A JP 2014506933 A5 JP2014506933 A5 JP 2014506933A5
- Authority
- JP
- Japan
- Prior art keywords
- carboxylic acid
- quinoxaline
- methyl
- amino
- isopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 25
- 229910052739 hydrogen Inorganic materials 0.000 claims 23
- 239000001257 hydrogen Substances 0.000 claims 23
- 150000002431 hydrogen Chemical class 0.000 claims 21
- 125000003118 aryl group Chemical group 0.000 claims 20
- 125000001072 heteroaryl group Chemical group 0.000 claims 19
- -1 stereoisomer Chemical class 0.000 claims 15
- 125000003710 aryl alkyl group Chemical group 0.000 claims 14
- 125000000753 cycloalkyl group Chemical group 0.000 claims 14
- 238000000034 method Methods 0.000 claims 12
- 125000000217 alkyl group Chemical group 0.000 claims 10
- 125000001475 halogen functional group Chemical group 0.000 claims 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 9
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 8
- 101100240518 Caenorhabditis elegans nhr-12 gene Proteins 0.000 claims 7
- 125000003342 alkenyl group Chemical group 0.000 claims 7
- 125000003545 alkoxy group Chemical group 0.000 claims 7
- 125000003282 alkyl amino group Chemical group 0.000 claims 7
- 125000000304 alkynyl group Chemical group 0.000 claims 7
- 125000004663 dialkyl amino group Chemical group 0.000 claims 7
- 125000001188 haloalkyl group Chemical group 0.000 claims 7
- 125000004475 heteroaralkyl group Chemical group 0.000 claims 7
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 7
- 125000000623 heterocyclic group Chemical group 0.000 claims 7
- 125000001424 substituent group Chemical group 0.000 claims 7
- 201000010099 disease Diseases 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- ZVNLQQKGXZSVPV-UHFFFAOYSA-N 2-(6-methoxypyridin-3-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound C1=NC(OC)=CC=C1C1=NC2=CC=C(C(O)=O)C=C2N=C1N(C)C(C)C ZVNLQQKGXZSVPV-UHFFFAOYSA-N 0.000 claims 4
- NYGQXUZKDABDDD-UHFFFAOYSA-N 2-(furan-2-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CO1 NYGQXUZKDABDDD-UHFFFAOYSA-N 0.000 claims 4
- 101000613563 Homo sapiens PAS domain-containing serine/threonine-protein kinase Proteins 0.000 claims 4
- 102100040902 PAS domain-containing serine/threonine-protein kinase Human genes 0.000 claims 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 4
- 150000002148 esters Chemical class 0.000 claims 4
- 239000000651 prodrug Substances 0.000 claims 4
- 229940002612 prodrug Drugs 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 208000030159 metabolic disease Diseases 0.000 claims 3
- JGQDBVXRYDEWGM-UHFFFAOYSA-N quinoxaline-6-carboxylic acid Chemical compound N1=CC=NC2=CC(C(=O)O)=CC=C21 JGQDBVXRYDEWGM-UHFFFAOYSA-N 0.000 claims 3
- 150000003626 triacylglycerols Chemical class 0.000 claims 3
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 2
- HLFUXGUPGUREQZ-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-3-(3,4-dihydro-2h-quinolin-1-yl)quinoxaline-6-carboxylic acid Chemical compound C1CCC2=CC=CC=C2N1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=C(OCO2)C2=C1 HLFUXGUPGUREQZ-UHFFFAOYSA-N 0.000 claims 2
- SEQCVAKNODWCHG-LBPRGKRZSA-N 2-(1,3-benzodioxol-5-yl)-3-[(2s)-2-methylpyrrolidin-1-yl]quinoxaline-6-carboxylic acid Chemical compound C[C@H]1CCCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(OCO2)C2=C1 SEQCVAKNODWCHG-LBPRGKRZSA-N 0.000 claims 2
- YRKANMKKKIUCMP-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound C1=C2OCOC2=CC(C2=NC3=CC=C(C=C3N=C2N(C)C(C)C)C(O)=O)=C1 YRKANMKKKIUCMP-UHFFFAOYSA-N 0.000 claims 2
- CFNMSJUXFABTQT-ZDUSSCGKSA-N 2-(1-benzofuran-2-yl)-3-[(2s)-2-methylpyrrolidin-1-yl]quinoxaline-6-carboxylic acid Chemical compound C[C@H]1CCCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC2=CC=CC=C2O1 CFNMSJUXFABTQT-ZDUSSCGKSA-N 0.000 claims 2
- FHNMMCLPYZSVDZ-UHFFFAOYSA-N 2-(1-benzofuran-2-yl)-3-[cyclopropyl(methyl)amino]quinoxaline-6-carboxylic acid Chemical compound N=1C2=CC(C(O)=O)=CC=C2N=C(C=2OC3=CC=CC=C3C=2)C=1N(C)C1CC1 FHNMMCLPYZSVDZ-UHFFFAOYSA-N 0.000 claims 2
- CWSJBZCDRYNELY-UHFFFAOYSA-N 2-(1-benzofuran-2-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound C1=CC=C2OC(C3=NC4=CC=C(C=C4N=C3N(C)C(C)C)C(O)=O)=CC2=C1 CWSJBZCDRYNELY-UHFFFAOYSA-N 0.000 claims 2
- LFCGWAMNIAAUGQ-UHFFFAOYSA-N 2-(1-methylindazol-6-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound C1=C2C=NN(C)C2=CC(C2=NC3=CC=C(C=C3N=C2N(C)C(C)C)C(O)=O)=C1 LFCGWAMNIAAUGQ-UHFFFAOYSA-N 0.000 claims 2
- USZAZKRESYUUIE-UHFFFAOYSA-N 2-(1h-indazol-5-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound C1=C2NN=CC2=CC(C2=NC3=CC=C(C=C3N=C2N(C)C(C)C)C(O)=O)=C1 USZAZKRESYUUIE-UHFFFAOYSA-N 0.000 claims 2
- JRCGWKOBBPLTDZ-UHFFFAOYSA-N 2-(1h-indazol-6-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound C1=C2C=NNC2=CC(C2=NC3=CC=C(C=C3N=C2N(C)C(C)C)C(O)=O)=C1 JRCGWKOBBPLTDZ-UHFFFAOYSA-N 0.000 claims 2
- XGXRTSSELDTWTK-UHFFFAOYSA-N 2-(1h-indol-2-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound C1=CC=C2NC(C3=NC4=CC=C(C=C4N=C3N(C)C(C)C)C(O)=O)=CC2=C1 XGXRTSSELDTWTK-UHFFFAOYSA-N 0.000 claims 2
- CNSXSBHPCWLUCI-UHFFFAOYSA-N 2-(1h-indol-5-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound C1=C2NC=CC2=CC(C2=NC3=CC=C(C=C3N=C2N(C)C(C)C)C(O)=O)=C1 CNSXSBHPCWLUCI-UHFFFAOYSA-N 0.000 claims 2
- ILQLSGSGRFZPHU-UHFFFAOYSA-N 2-(1h-indol-6-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound C1=C2C=CNC2=CC(C2=NC3=CC=C(C=C3N=C2N(C)C(C)C)C(O)=O)=C1 ILQLSGSGRFZPHU-UHFFFAOYSA-N 0.000 claims 2
- RCCVMGLYQAFOIY-UHFFFAOYSA-N 2-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound O1CCOC2=CC(C3=NC4=CC=C(C=C4N=C3N(C)C(C)C)C(O)=O)=CC=C21 RCCVMGLYQAFOIY-UHFFFAOYSA-N 0.000 claims 2
- KRZULGJBWBRGEQ-UHFFFAOYSA-N 2-(5-bromopyridin-3-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CN=CC(Br)=C1 KRZULGJBWBRGEQ-UHFFFAOYSA-N 0.000 claims 2
- YGQKOJRXHPYFRY-UHFFFAOYSA-N 2-(5-cyanopyridin-2-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(C#N)C=N1 YGQKOJRXHPYFRY-UHFFFAOYSA-N 0.000 claims 2
- JANPZECAFMRBBL-UHFFFAOYSA-N 2-(5-fluoro-1-benzofuran-2-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound FC1=CC=C2OC(C3=NC4=CC=C(C=C4N=C3N(C)C(C)C)C(O)=O)=CC2=C1 JANPZECAFMRBBL-UHFFFAOYSA-N 0.000 claims 2
- GQOYPLTYLTWORC-UHFFFAOYSA-N 2-(5-fluoro-1h-indol-2-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound FC1=CC=C2NC(C3=NC4=CC=C(C=C4N=C3N(C)C(C)C)C(O)=O)=CC2=C1 GQOYPLTYLTWORC-UHFFFAOYSA-N 0.000 claims 2
- WWEVFFRIVAKHLD-UHFFFAOYSA-N 2-(5-fluoropyridin-2-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(F)C=N1 WWEVFFRIVAKHLD-UHFFFAOYSA-N 0.000 claims 2
- FERDABDGEUBFHB-UHFFFAOYSA-N 2-(5-methoxy-1h-indol-2-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound C1=C(C(O)=O)C=C2N=C(N(C)C(C)C)C(C=3NC4=CC=C(C=C4C=3)OC)=NC2=C1 FERDABDGEUBFHB-UHFFFAOYSA-N 0.000 claims 2
- YPQAIUIPIWEOLN-UHFFFAOYSA-N 2-(6-fluoropyridin-3-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(F)N=C1 YPQAIUIPIWEOLN-UHFFFAOYSA-N 0.000 claims 2
- KUPWMFCQISUHSP-UHFFFAOYSA-N 2-[5-methoxy-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound C1=C(C(O)=O)C=C2N=C(N(C)C(C)C)C(C=3N(C(=O)OC(C)(C)C)C4=CC=C(C=C4C=3)OC)=NC2=C1 KUPWMFCQISUHSP-UHFFFAOYSA-N 0.000 claims 2
- WBPJYDOVOKDDEU-UHFFFAOYSA-N 2-imidazo[1,2-a]pyridin-6-yl-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound C1=CC2=NC=CN2C=C1C1=NC2=CC=C(C(O)=O)C=C2N=C1N(C)C(C)C WBPJYDOVOKDDEU-UHFFFAOYSA-N 0.000 claims 2
- BLVMMHBXXZHNCN-UHFFFAOYSA-N 2-phenyl-3-[4-[4-(trifluoromethyl)phenyl]piperazin-1-yl]quinoxaline-6-carboxylic acid Chemical compound C1CN(C=2C=CC(=CC=2)C(F)(F)F)CCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 BLVMMHBXXZHNCN-UHFFFAOYSA-N 0.000 claims 2
- MODHPFWYLIVFGN-ZDUSSCGKSA-N 3-[(2s)-2-methylpyrrolidin-1-yl]-2-phenylquinoxaline-6-carboxylic acid Chemical compound C[C@H]1CCCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 MODHPFWYLIVFGN-ZDUSSCGKSA-N 0.000 claims 2
- YHBOSGHZPVZHJA-UHFFFAOYSA-N 3-[butan-2-yl(methyl)amino]-2-(furan-3-yl)quinoxaline-6-carboxylic acid Chemical compound CCC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C=1C=COC=1 YHBOSGHZPVZHJA-UHFFFAOYSA-N 0.000 claims 2
- JRDQPIWWMSUIFP-UHFFFAOYSA-N 3-[methyl(propan-2-yl)amino]-2-(1h-pyrazol-4-yl)quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C=1C=NNC=1 JRDQPIWWMSUIFP-UHFFFAOYSA-N 0.000 claims 2
- GECQESOIABNQFL-UHFFFAOYSA-N 3-[methyl(propan-2-yl)amino]-2-(5-methylthiophen-2-yl)quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(C)S1 GECQESOIABNQFL-UHFFFAOYSA-N 0.000 claims 2
- RHPXGFFWAQKXLZ-UHFFFAOYSA-N 3-[methyl(propan-2-yl)amino]-2-(6-pyrrolidin-1-ylpyridin-3-yl)quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C(C=N1)=CC=C1N1CCCC1 RHPXGFFWAQKXLZ-UHFFFAOYSA-N 0.000 claims 2
- OEPYLQJBIZMUHC-UHFFFAOYSA-N 3-[methyl(propan-2-yl)amino]-2-[1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]quinoxaline-6-carboxylic acid Chemical compound C1=CC=C2N(C(=O)OC(C)(C)C)C(C3=NC4=CC=C(C=C4N=C3N(C)C(C)C)C(O)=O)=CC2=C1 OEPYLQJBIZMUHC-UHFFFAOYSA-N 0.000 claims 2
- KCVSARQTGWRMQX-UHFFFAOYSA-N 3-[methyl(propan-2-yl)amino]-2-[5-(trifluoromethyl)-1h-pyrazol-4-yl]quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CNN=C1C(F)(F)F KCVSARQTGWRMQX-UHFFFAOYSA-N 0.000 claims 2
- UBVFIAGJSKWPMP-UHFFFAOYSA-N 3-[methyl(propan-2-yl)amino]-2-[5-(trifluoromethyl)pyridin-2-yl]quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(C(F)(F)F)C=N1 UBVFIAGJSKWPMP-UHFFFAOYSA-N 0.000 claims 2
- NJNMZMMUBCJUBI-UHFFFAOYSA-N 3-[methyl(propan-2-yl)amino]-2-[6-(trifluoromethyl)pyridin-3-yl]quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(C(F)(F)F)N=C1 NJNMZMMUBCJUBI-UHFFFAOYSA-N 0.000 claims 2
- APEKBSGYHGDFKW-UHFFFAOYSA-N 3-[methyl(propan-2-yl)amino]-2-[6-[(2-methylpropan-2-yl)oxycarbonylamino]pyridin-3-yl]quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(NC(=O)OC(C)(C)C)N=C1 APEKBSGYHGDFKW-UHFFFAOYSA-N 0.000 claims 2
- GGZSTHJCJLFQGE-UHFFFAOYSA-N 3-[methyl(propan-2-yl)amino]-2-pyridin-3-ylquinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CN=C1 GGZSTHJCJLFQGE-UHFFFAOYSA-N 0.000 claims 2
- NBFBCBUZNAPMHI-UHFFFAOYSA-N 3-[methyl(propan-2-yl)amino]-2-pyridin-4-ylquinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=NC=C1 NBFBCBUZNAPMHI-UHFFFAOYSA-N 0.000 claims 2
- KSFBFGMTIZTXTJ-UHFFFAOYSA-N 3-[methyl(propan-2-yl)amino]-2-quinolin-3-ylquinoxaline-6-carboxylic acid Chemical compound C1=CC=CC2=CC(C3=NC4=CC=C(C=C4N=C3N(C)C(C)C)C(O)=O)=CN=C21 KSFBFGMTIZTXTJ-UHFFFAOYSA-N 0.000 claims 2
- LBVJIOYUNKVJGB-UHFFFAOYSA-N 3-[methyl(propan-2-yl)amino]-2-thiophen-2-ylquinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CS1 LBVJIOYUNKVJGB-UHFFFAOYSA-N 0.000 claims 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 2
- 208000032928 Dyslipidaemia Diseases 0.000 claims 2
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 2
- 235000012000 cholesterol Nutrition 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 125000004438 haloalkoxy group Chemical group 0.000 claims 2
- 125000006588 heterocycloalkylene group Chemical group 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 claims 1
- 125000006728 (C1-C6) alkynyl group Chemical group 0.000 claims 1
- JXWYOCARONMUEH-UHFFFAOYSA-N 2,3-bis(4-methoxyphenyl)-6-(2h-tetrazol-5-yl)quinoxaline Chemical compound C1=CC(OC)=CC=C1C1=NC2=CC=C(C=3NN=NN=3)C=C2N=C1C1=CC=C(OC)C=C1 JXWYOCARONMUEH-UHFFFAOYSA-N 0.000 claims 1
- XKCVTJZYYCAGBO-UHFFFAOYSA-N 2,3-bis(4-phenylpiperidin-1-yl)quinoxaline-6-carboxylic acid Chemical compound C1CC(C=2C=CC=CC=2)CCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1N(CC1)CCC1C1=CC=CC=C1 XKCVTJZYYCAGBO-UHFFFAOYSA-N 0.000 claims 1
- GKYXNXDROGWCFH-UHFFFAOYSA-N 2-(1-benzofuran-2-yl)-3-[butan-2-yl(methyl)amino]quinoxaline-6-carboxylic acid Chemical compound C1=CC=C2OC(C3=NC4=CC=C(C=C4N=C3N(C)C(C)CC)C(O)=O)=CC2=C1 GKYXNXDROGWCFH-UHFFFAOYSA-N 0.000 claims 1
- GNRXVCZFRPECGI-UHFFFAOYSA-N 2-(2-fluorophenyl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1F GNRXVCZFRPECGI-UHFFFAOYSA-N 0.000 claims 1
- ZWCJLTGYJAFRFZ-UHFFFAOYSA-N 2-(3,4-difluorophenyl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(F)C(F)=C1 ZWCJLTGYJAFRFZ-UHFFFAOYSA-N 0.000 claims 1
- JMDMGVXBOASNDN-UHFFFAOYSA-N 2-(3-fluorophenyl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC(F)=C1 JMDMGVXBOASNDN-UHFFFAOYSA-N 0.000 claims 1
- SAZXAYVKLHFVGW-UHFFFAOYSA-N 2-(3-methoxyphenyl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound COC1=CC=CC(C=2C(=NC3=CC(=CC=C3N=2)C(O)=O)N(C)C(C)C)=C1 SAZXAYVKLHFVGW-UHFFFAOYSA-N 0.000 claims 1
- PWGUMJNASSFPEW-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(Cl)C=C1 PWGUMJNASSFPEW-UHFFFAOYSA-N 0.000 claims 1
- NNIZYTUOCXKYCZ-UHFFFAOYSA-N 2-(4-cyanophenyl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(C#N)C=C1 NNIZYTUOCXKYCZ-UHFFFAOYSA-N 0.000 claims 1
- ZRGDEEHQBXOIQU-UHFFFAOYSA-N 2-(4-fluorophenyl)-3-(3-methylpiperidin-1-yl)quinoxaline-6-carboxylic acid Chemical compound C1C(C)CCCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(F)C=C1 ZRGDEEHQBXOIQU-UHFFFAOYSA-N 0.000 claims 1
- JSWQYEUTVFKVSA-UHFFFAOYSA-N 2-(4-fluorophenyl)-3-(3-oxopiperazin-1-yl)quinoxaline-6-carboxylic acid Chemical compound C1CNC(=O)CN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=C(F)C=C1 JSWQYEUTVFKVSA-UHFFFAOYSA-N 0.000 claims 1
- KONRKDNGLRDGCS-MRXNPFEDSA-N 2-(4-fluorophenyl)-3-[(2r)-2-(methoxymethyl)pyrrolidin-1-yl]quinoxaline-6-carboxylic acid Chemical compound COC[C@H]1CCCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(F)C=C1 KONRKDNGLRDGCS-MRXNPFEDSA-N 0.000 claims 1
- RNXGPLPQCMLPKK-INIZCTEOSA-N 2-(4-fluorophenyl)-3-[(2s)-2-methyl-4-pyridin-2-ylpiperazin-1-yl]quinoxaline-6-carboxylic acid Chemical compound C([C@@H]1C)N(C=2N=CC=CC=2)CCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(F)C=C1 RNXGPLPQCMLPKK-INIZCTEOSA-N 0.000 claims 1
- BXYWNNBCTFBNED-ZDUSSCGKSA-N 2-(4-fluorophenyl)-3-[(2s)-2-methylpiperidin-1-yl]quinoxaline-6-carboxylic acid Chemical compound C[C@H]1CCCCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(F)C=C1 BXYWNNBCTFBNED-ZDUSSCGKSA-N 0.000 claims 1
- DZRUCRKWBXDZRX-LBPRGKRZSA-N 2-(4-fluorophenyl)-3-[(2s)-2-methylpyrrolidin-1-yl]quinoxaline-6-carboxylic acid Chemical compound C[C@H]1CCCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(F)C=C1 DZRUCRKWBXDZRX-LBPRGKRZSA-N 0.000 claims 1
- BESVKGQEYPPWDB-UHFFFAOYSA-N 2-(4-fluorophenyl)-3-[3-(methoxymethyl)piperidin-1-yl]quinoxaline-6-carboxylic acid Chemical compound C1C(COC)CCCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(F)C=C1 BESVKGQEYPPWDB-UHFFFAOYSA-N 0.000 claims 1
- ZOIQHJYRKIJRGL-UHFFFAOYSA-N 2-(4-fluorophenyl)-3-[methyl(oxan-4-yl)amino]quinoxaline-6-carboxylic acid Chemical compound N=1C2=CC(C(O)=O)=CC=C2N=C(C=2C=CC(F)=CC=2)C=1N(C)C1CCOCC1 ZOIQHJYRKIJRGL-UHFFFAOYSA-N 0.000 claims 1
- YBSWQCILJHSKIU-UHFFFAOYSA-N 2-(4-fluorophenyl)-3-[methyl(piperidin-4-yl)amino]quinoxaline-6-carboxylic acid Chemical compound N=1C2=CC(C(O)=O)=CC=C2N=C(C=2C=CC(F)=CC=2)C=1N(C)C1CCNCC1 YBSWQCILJHSKIU-UHFFFAOYSA-N 0.000 claims 1
- JKKRYYTVQXUOKL-UHFFFAOYSA-N 2-(4-fluorophenyl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(F)C=C1 JKKRYYTVQXUOKL-UHFFFAOYSA-N 0.000 claims 1
- JSLJEZDXSJJQFG-UHFFFAOYSA-N 2-(4-methoxyphenyl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound C1=CC(OC)=CC=C1C1=NC2=CC=C(C(O)=O)C=C2N=C1N(C)C(C)C JSLJEZDXSJJQFG-UHFFFAOYSA-N 0.000 claims 1
- PCXIATWDOZIUHJ-UHFFFAOYSA-N 2-(5-chloro-1-benzofuran-2-yl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid Chemical compound ClC1=CC=C2OC(C3=NC4=CC=C(C=C4N=C3N(C)C(C)C)C(O)=O)=CC2=C1 PCXIATWDOZIUHJ-UHFFFAOYSA-N 0.000 claims 1
- IOQRYMVDJHUTPG-UHFFFAOYSA-N 2-(azepan-1-yl)-3-phenylquinoxaline-6-carboxylic acid Chemical compound C=1C=CC=CC=1C1=NC2=CC(C(=O)O)=CC=C2N=C1N1CCCCCC1 IOQRYMVDJHUTPG-UHFFFAOYSA-N 0.000 claims 1
- UDUVOFRHBXMEAU-UHFFFAOYSA-N 2-[4-(3-chlorophenyl)piperidin-1-yl]-3-(4-fluorophenyl)quinoxaline-6-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1=NC2=CC(C(=O)O)=CC=C2N=C1N(CC1)CCC1C1=CC=CC(Cl)=C1 UDUVOFRHBXMEAU-UHFFFAOYSA-N 0.000 claims 1
- UKFDKTCZAAYLSR-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)piperidin-1-yl]-3-(4-fluorophenyl)quinoxaline-6-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1=NC2=CC(C(=O)O)=CC=C2N=C1N(CC1)CCC1C1=CC=C(Cl)C=C1 UKFDKTCZAAYLSR-UHFFFAOYSA-N 0.000 claims 1
- HTVPAGXKVGAZQE-UHFFFAOYSA-N 2-phenyl-3-(2-phenylethylamino)quinoxaline-6-carboxylic acid Chemical compound N=1C2=CC(C(=O)O)=CC=C2N=C(C=2C=CC=CC=2)C=1NCCC1=CC=CC=C1 HTVPAGXKVGAZQE-UHFFFAOYSA-N 0.000 claims 1
- KTIROGJCOITTNP-UHFFFAOYSA-N 2-phenyl-3-(4-phenylpiperazin-1-yl)quinoxaline-6-carboxylic acid Chemical compound C1CN(C=2C=CC=CC=2)CCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 KTIROGJCOITTNP-UHFFFAOYSA-N 0.000 claims 1
- VBOARJZBQGMIEJ-UHFFFAOYSA-N 2-phenyl-3-(4-phenylpiperidin-1-yl)quinoxaline-6-carboxylic acid Chemical compound C1CC(C=2C=CC=CC=2)CCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 VBOARJZBQGMIEJ-UHFFFAOYSA-N 0.000 claims 1
- ALUNRJJRXDRTNS-UHFFFAOYSA-N 2-phenyl-3-(4-pyrimidin-2-ylpiperazin-1-yl)quinoxaline-6-carboxylic acid Chemical compound C1CN(C=2N=CC=CN=2)CCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 ALUNRJJRXDRTNS-UHFFFAOYSA-N 0.000 claims 1
- SGEDGUNHRNELJK-UHFFFAOYSA-N 2-phenyl-3-(4-quinolin-2-ylpiperazin-1-yl)quinoxaline-6-carboxylic acid Chemical compound C1CN(C=2N=C3C=CC=CC3=CC=2)CCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 SGEDGUNHRNELJK-UHFFFAOYSA-N 0.000 claims 1
- TWTQQTMBJLBKKS-UHFFFAOYSA-N 2-phenyl-3-(propan-2-ylamino)quinoxaline-6-carboxylic acid Chemical compound CC(C)NC1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 TWTQQTMBJLBKKS-UHFFFAOYSA-N 0.000 claims 1
- UZOQISATLXPBPB-MRXNPFEDSA-N 2-phenyl-3-[(2r)-2-(trifluoromethyl)pyrrolidin-1-yl]quinoxaline-6-carboxylic acid Chemical compound N1([C@H](CCC1)C(F)(F)F)C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 UZOQISATLXPBPB-MRXNPFEDSA-N 0.000 claims 1
- KYMQKAODIPAHDO-UHFFFAOYSA-N 2-phenyl-3-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]quinoxaline-6-carboxylic acid Chemical compound C1CC(C=2C=CC(=CC=2)C(F)(F)F)CCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 KYMQKAODIPAHDO-UHFFFAOYSA-N 0.000 claims 1
- ZPXWVIFNUUUDPR-UHFFFAOYSA-N 2-phenyl-3-[4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]quinoxaline-6-carboxylic acid Chemical compound C1CN(C=2N=CC(=CC=2)C(F)(F)F)CCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 ZPXWVIFNUUUDPR-UHFFFAOYSA-N 0.000 claims 1
- OYRQAUBBVFRQJI-UHFFFAOYSA-N 2-phenyl-3-piperazin-1-ylquinoxaline-6-carboxylic acid Chemical compound C1CNCCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 OYRQAUBBVFRQJI-UHFFFAOYSA-N 0.000 claims 1
- QNWSYLAQEPRNTF-UHFFFAOYSA-N 2-phenyl-3-piperidin-1-ylquinoxaline-6-carboxylic acid Chemical compound C1CCCCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 QNWSYLAQEPRNTF-UHFFFAOYSA-N 0.000 claims 1
- BRLJMTPGCJFYGH-UHFFFAOYSA-N 3-(2,3-dihydro-1,4-benzoxazin-4-yl)-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1COC2=CC=CC=C2N1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 BRLJMTPGCJFYGH-UHFFFAOYSA-N 0.000 claims 1
- ZPCBICMHXHXJKV-UHFFFAOYSA-N 3-(2,3-dihydroindol-1-yl)-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1CC2=CC=CC=C2N1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 ZPCBICMHXHXJKV-UHFFFAOYSA-N 0.000 claims 1
- HEYDRRQYMSWMSI-UHFFFAOYSA-N 3-(2-methylpiperidin-1-yl)-2-phenylquinoxaline-6-carboxylic acid Chemical compound CC1CCCCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 HEYDRRQYMSWMSI-UHFFFAOYSA-N 0.000 claims 1
- MODHPFWYLIVFGN-UHFFFAOYSA-N 3-(2-methylpyrrolidin-1-yl)-2-phenylquinoxaline-6-carboxylic acid Chemical compound CC1CCCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 MODHPFWYLIVFGN-UHFFFAOYSA-N 0.000 claims 1
- WFZHQPVGJAHSMC-UHFFFAOYSA-N 3-(3,3-dimethylpiperidin-1-yl)-2-(4-fluorophenyl)quinoxaline-6-carboxylic acid Chemical compound C1C(C)(C)CCCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(F)C=C1 WFZHQPVGJAHSMC-UHFFFAOYSA-N 0.000 claims 1
- PVYJSQUAGIFHMT-UHFFFAOYSA-N 3-(3,4,4a,5,6,7,8,8a-octahydro-2h-quinolin-1-yl)-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1CCC2CCCCC2N1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 PVYJSQUAGIFHMT-UHFFFAOYSA-N 0.000 claims 1
- WGOOJGCSXFSODR-UHFFFAOYSA-N 3-(3,4-dihydro-1h-isoquinolin-2-yl)-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1CC2=CC=CC=C2CN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 WGOOJGCSXFSODR-UHFFFAOYSA-N 0.000 claims 1
- QNTAFDGTGJMGAA-UHFFFAOYSA-N 3-(3,4-dihydro-2h-quinolin-1-yl)-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1CCC2=CC=CC=C2N1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 QNTAFDGTGJMGAA-UHFFFAOYSA-N 0.000 claims 1
- PRHUXQAFHYAZOS-UHFFFAOYSA-N 3-(3-methylmorpholin-4-yl)-2-phenylquinoxaline-6-carboxylic acid Chemical compound CC1COCCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 PRHUXQAFHYAZOS-UHFFFAOYSA-N 0.000 claims 1
- VYWWYKKBSKHRBG-UHFFFAOYSA-N 3-(4-acetamidopiperidin-1-yl)-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1CC(NC(=O)C)CCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 VYWWYKKBSKHRBG-UHFFFAOYSA-N 0.000 claims 1
- KPDGUUJODHKQHI-UHFFFAOYSA-N 3-(4-fluorophenyl)-2-(4-pyridin-2-ylpiperazin-1-yl)quinoxaline-6-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1=NC2=CC(C(=O)O)=CC=C2N=C1N(CC1)CCN1C1=CC=CC=N1 KPDGUUJODHKQHI-UHFFFAOYSA-N 0.000 claims 1
- DKHGDKUUKKIFFR-UHFFFAOYSA-N 3-(4-fluorophenyl)-2-[4-(4-methoxyphenyl)piperidin-1-yl]quinoxaline-6-carboxylic acid Chemical compound C1=CC(OC)=CC=C1C1CCN(C=2C(=NC3=CC(=CC=C3N=2)C(O)=O)C=2C=CC(F)=CC=2)CC1 DKHGDKUUKKIFFR-UHFFFAOYSA-N 0.000 claims 1
- XNQAOBKHXBGGHD-UHFFFAOYSA-N 3-(4-fluorophenyl)-2-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]quinoxaline-6-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1=NC2=CC(C(=O)O)=CC=C2N=C1N(CC1)CCC1C1=CC=C(C(F)(F)F)C=C1 XNQAOBKHXBGGHD-UHFFFAOYSA-N 0.000 claims 1
- WQLHETUGEZSAQT-UHFFFAOYSA-N 3-(4-methyl-1,4-diazepan-1-yl)-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1CN(C)CCCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 WQLHETUGEZSAQT-UHFFFAOYSA-N 0.000 claims 1
- JWIOHBJBAYIYGD-UHFFFAOYSA-N 3-(4-methylpiperazin-1-yl)-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1CN(C)CCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 JWIOHBJBAYIYGD-UHFFFAOYSA-N 0.000 claims 1
- VDKYIZMOOPPJRF-UHFFFAOYSA-N 3-(4-methylsulfonylpiperazin-1-yl)-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1CN(S(=O)(=O)C)CCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 VDKYIZMOOPPJRF-UHFFFAOYSA-N 0.000 claims 1
- CALMFUDXDNPGQC-UHFFFAOYSA-N 3-(6-methoxy-3,4-dihydro-2h-quinolin-1-yl)-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1CCC2=CC(OC)=CC=C2N1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 CALMFUDXDNPGQC-UHFFFAOYSA-N 0.000 claims 1
- QYKVCCCMPASUMG-UHFFFAOYSA-N 3-(azepan-1-yl)-2-(4-fluorophenyl)quinoxaline-6-carboxylic acid Chemical compound C1CCCCCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=C(F)C=C1 QYKVCCCMPASUMG-UHFFFAOYSA-N 0.000 claims 1
- CRNBFDSASPQSIZ-UHFFFAOYSA-N 3-(azepan-1-yl)-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1CCCCCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 CRNBFDSASPQSIZ-UHFFFAOYSA-N 0.000 claims 1
- XELMYGGXYVNIMI-UHFFFAOYSA-N 3-(cyclohexylamino)-2-phenylquinoxaline-6-carboxylic acid Chemical compound N=1C2=CC(C(=O)O)=CC=C2N=C(C=2C=CC=CC=2)C=1NC1CCCCC1 XELMYGGXYVNIMI-UHFFFAOYSA-N 0.000 claims 1
- FOCBNROQRJKFDF-UHFFFAOYSA-N 3-(diethylamino)-2-phenylquinoxaline-6-carboxylic acid Chemical compound CCN(CC)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 FOCBNROQRJKFDF-UHFFFAOYSA-N 0.000 claims 1
- RSHYJNDBLZXSLE-OAHLLOKOSA-N 3-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-phenylquinoxaline-6-carboxylic acid Chemical compound OC[C@H]1CCCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 RSHYJNDBLZXSLE-OAHLLOKOSA-N 0.000 claims 1
- GCWKGSYISCSWKX-MRXNPFEDSA-N 3-[(2r)-2-(methoxymethyl)pyrrolidin-1-yl]-2-phenylquinoxaline-6-carboxylic acid Chemical compound COC[C@H]1CCCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 GCWKGSYISCSWKX-MRXNPFEDSA-N 0.000 claims 1
- RSHYJNDBLZXSLE-HNNXBMFYSA-N 3-[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-phenylquinoxaline-6-carboxylic acid Chemical compound OC[C@@H]1CCCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 RSHYJNDBLZXSLE-HNNXBMFYSA-N 0.000 claims 1
- AVFSFVQKIPZUOQ-KRWDZBQOSA-N 3-[(2s)-2-methyl-4-pyridin-2-ylpiperazin-1-yl]-2-phenylquinoxaline-6-carboxylic acid Chemical compound C([C@@H]1C)N(C=2N=CC=CC=2)CCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 AVFSFVQKIPZUOQ-KRWDZBQOSA-N 0.000 claims 1
- HHMZHNSQCKBNQA-CQSZACIVSA-N 3-[(3r)-3-hydroxypyrrolidin-1-yl]-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1[C@H](O)CCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 HHMZHNSQCKBNQA-CQSZACIVSA-N 0.000 claims 1
- HHMZHNSQCKBNQA-AWEZNQCLSA-N 3-[(3s)-3-hydroxypyrrolidin-1-yl]-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1[C@@H](O)CCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 HHMZHNSQCKBNQA-AWEZNQCLSA-N 0.000 claims 1
- JWUSFZKTVHCNLX-UHFFFAOYSA-N 3-[4-(3-chlorophenyl)piperazin-1-yl]-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1CN(C=2C=C(Cl)C=CC=2)CCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 JWUSFZKTVHCNLX-UHFFFAOYSA-N 0.000 claims 1
- SWHUGSSYBZZLMR-UHFFFAOYSA-N 3-[4-(3-chlorophenyl)piperidin-1-yl]-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1CC(C=2C=C(Cl)C=CC=2)CCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 SWHUGSSYBZZLMR-UHFFFAOYSA-N 0.000 claims 1
- ZZDAZWSQMIAHCM-UHFFFAOYSA-N 3-[4-(4-chlorophenyl)piperazin-1-yl]-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1CN(C=2C=CC(Cl)=CC=2)CCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 ZZDAZWSQMIAHCM-UHFFFAOYSA-N 0.000 claims 1
- JFVNRPQVVVJISO-UHFFFAOYSA-N 3-[4-(4-chlorophenyl)piperidin-1-yl]-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1CC(C=2C=CC(Cl)=CC=2)CCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 JFVNRPQVVVJISO-UHFFFAOYSA-N 0.000 claims 1
- CLSXIBQTHKVJFG-UHFFFAOYSA-N 3-[4-(4-methoxyphenyl)piperazin-1-yl]-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C(=NC3=CC=C(C=C3N=2)C(O)=O)C=2C=CC=CC=2)CC1 CLSXIBQTHKVJFG-UHFFFAOYSA-N 0.000 claims 1
- GJVIFNUGJGZAAJ-UHFFFAOYSA-N 3-[4-(4-methoxyphenyl)piperidin-1-yl]-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1=CC(OC)=CC=C1C1CCN(C=2C(=NC3=CC=C(C=C3N=2)C(O)=O)C=2C=CC=CC=2)CC1 GJVIFNUGJGZAAJ-UHFFFAOYSA-N 0.000 claims 1
- OIERDXDJSUXCJG-UHFFFAOYSA-N 3-[4-(n-methylanilino)piperidin-1-yl]-2-phenylquinoxaline-6-carboxylic acid Chemical compound C=1C=CC=CC=1N(C)C(CC1)CCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 OIERDXDJSUXCJG-UHFFFAOYSA-N 0.000 claims 1
- NHXLUQIXGAZLHB-UHFFFAOYSA-N 3-[4-[acetyl(methyl)amino]piperidin-1-yl]-2-(4-fluorophenyl)quinoxaline-6-carboxylic acid Chemical compound C1CC(N(C)C(C)=O)CCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(F)C=C1 NHXLUQIXGAZLHB-UHFFFAOYSA-N 0.000 claims 1
- ZWSXQSUVWDSQRL-UHFFFAOYSA-N 3-[4-[acetyl(methyl)amino]piperidin-1-yl]-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1CC(N(C)C(C)=O)CCN1C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 ZWSXQSUVWDSQRL-UHFFFAOYSA-N 0.000 claims 1
- LTZGWNSNJBIENC-CYBMUJFWSA-N 3-[[(2r)-butan-2-yl]-methylamino]-2-phenylquinoxaline-6-carboxylic acid Chemical compound CC[C@@H](C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 LTZGWNSNJBIENC-CYBMUJFWSA-N 0.000 claims 1
- LDNIALWGVHIOJL-LBPRGKRZSA-N 3-[[(2s)-butan-2-yl]-methylamino]-2-(4-fluorophenyl)quinoxaline-6-carboxylic acid Chemical compound CC[C@H](C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(F)C=C1 LDNIALWGVHIOJL-LBPRGKRZSA-N 0.000 claims 1
- LTZGWNSNJBIENC-UHFFFAOYSA-N 3-[butan-2-yl(methyl)amino]-2-phenylquinoxaline-6-carboxylic acid Chemical compound CCC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 LTZGWNSNJBIENC-UHFFFAOYSA-N 0.000 claims 1
- PZHDDPXCAAUDKJ-UHFFFAOYSA-N 3-[cyclopentyl(methyl)amino]-2-(4-fluorophenyl)quinoxaline-6-carboxylic acid Chemical compound N=1C2=CC(C(O)=O)=CC=C2N=C(C=2C=CC(F)=CC=2)C=1N(C)C1CCCC1 PZHDDPXCAAUDKJ-UHFFFAOYSA-N 0.000 claims 1
- BKUWVWJDONBNID-UHFFFAOYSA-N 3-[cyclopentyl(methyl)amino]-2-phenylquinoxaline-6-carboxylic acid Chemical compound N=1C2=CC(C(O)=O)=CC=C2N=C(C=2C=CC=CC=2)C=1N(C)C1CCCC1 BKUWVWJDONBNID-UHFFFAOYSA-N 0.000 claims 1
- MXKVHKAMSDKJOV-UHFFFAOYSA-N 3-[cyclopropyl(methyl)amino]-2-(4-fluorophenyl)quinoxaline-6-carboxylic acid Chemical compound N=1C2=CC(C(O)=O)=CC=C2N=C(C=2C=CC(F)=CC=2)C=1N(C)C1CC1 MXKVHKAMSDKJOV-UHFFFAOYSA-N 0.000 claims 1
- IITMEKDTKBWXSY-UHFFFAOYSA-N 3-[cyclopropyl(methyl)amino]-2-phenylquinoxaline-6-carboxylic acid Chemical compound N=1C2=CC(C(O)=O)=CC=C2N=C(C=2C=CC=CC=2)C=1N(C)C1CC1 IITMEKDTKBWXSY-UHFFFAOYSA-N 0.000 claims 1
- DIHPRBCCRNGYHE-UHFFFAOYSA-N 3-[methyl(2-phenylethyl)amino]-2-phenylquinoxaline-6-carboxylic acid Chemical compound N=1C2=CC(C(O)=O)=CC=C2N=C(C=2C=CC=CC=2)C=1N(C)CCC1=CC=CC=C1 DIHPRBCCRNGYHE-UHFFFAOYSA-N 0.000 claims 1
- UYYUINZFBGYMJD-UHFFFAOYSA-N 3-[methyl(propan-2-yl)amino]-2-(4-methylsulfonylphenyl)quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(S(C)(=O)=O)C=C1 UYYUINZFBGYMJD-UHFFFAOYSA-N 0.000 claims 1
- VBZITIJQDVOHQY-UHFFFAOYSA-N 3-[methyl(propan-2-yl)amino]-2-(4-morpholin-4-ylphenyl)quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C(C=C1)=CC=C1N1CCOCC1 VBZITIJQDVOHQY-UHFFFAOYSA-N 0.000 claims 1
- HUUWVMRTOMEUIK-UHFFFAOYSA-N 3-[methyl(propan-2-yl)amino]-2-[4-(trifluoromethoxy)phenyl]quinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=C(OC(F)(F)F)C=C1 HUUWVMRTOMEUIK-UHFFFAOYSA-N 0.000 claims 1
- KAHWLDVDHKQLSX-UHFFFAOYSA-N 3-[methyl(propan-2-yl)amino]-2-phenylquinoxaline-6-carboxylic acid Chemical compound CC(C)N(C)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 KAHWLDVDHKQLSX-UHFFFAOYSA-N 0.000 claims 1
- BAGVMYQIIZVDCW-MRXNPFEDSA-N 3-[methyl-[(1r)-1-phenylethyl]amino]-2-phenylquinoxaline-6-carboxylic acid Chemical compound CN([C@H](C)C=1C=CC=CC=1)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 BAGVMYQIIZVDCW-MRXNPFEDSA-N 0.000 claims 1
- BAGVMYQIIZVDCW-INIZCTEOSA-N 3-[methyl-[(1s)-1-phenylethyl]amino]-2-phenylquinoxaline-6-carboxylic acid Chemical compound CN([C@@H](C)C=1C=CC=CC=1)C1=NC2=CC(C(O)=O)=CC=C2N=C1C1=CC=CC=C1 BAGVMYQIIZVDCW-INIZCTEOSA-N 0.000 claims 1
- OIRPGAZNLOQRDX-UHFFFAOYSA-N 3-indol-1-yl-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1=CC2=CC=CC=C2N1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 OIRPGAZNLOQRDX-UHFFFAOYSA-N 0.000 claims 1
- RVIHPCCTLCBNIH-UHFFFAOYSA-N 3-morpholin-4-yl-2-phenylquinoxaline-6-carboxylic acid Chemical compound C1COCCN1C1=NC2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 RVIHPCCTLCBNIH-UHFFFAOYSA-N 0.000 claims 1
- VBOLZYIAZQWHMQ-UHFFFAOYSA-N 3-phenyl-2-piperidin-1-ylquinoxaline-6-carboxylic acid Chemical compound C=1C=CC=CC=1C1=NC2=CC(C(=O)O)=CC=C2N=C1N1CCCCC1 VBOLZYIAZQWHMQ-UHFFFAOYSA-N 0.000 claims 1
- 102000007513 Hemoglobin A Human genes 0.000 claims 1
- 108010085682 Hemoglobin A Proteins 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- IYWVRFMWSYCCTO-UHFFFAOYSA-N O(C)C1=CC=C(C=C1)C1=NC2=CC=C(C=C2N=C1)C(=O)O Chemical compound O(C)C1=CC=C(C=C1)C1=NC2=CC=C(C=C2N=C1)C(=O)O IYWVRFMWSYCCTO-UHFFFAOYSA-N 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 241000270666 Testudines Species 0.000 claims 1
- 108010069201 VLDL Cholesterol Proteins 0.000 claims 1
- 239000005862 Whey Substances 0.000 claims 1
- 102000007544 Whey Proteins Human genes 0.000 claims 1
- 108010046377 Whey Proteins Proteins 0.000 claims 1
- 230000001668 ameliorated effect Effects 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- LNTSWYUOHQDHBB-UHFFFAOYSA-N butyl 2-(4-fluorophenyl)-3-piperidin-1-ylquinoxaline-6-carboxylate Chemical compound C1CCCCN1C1=NC2=CC(C(=O)OCCCC)=CC=C2N=C1C1=CC=C(F)C=C1 LNTSWYUOHQDHBB-UHFFFAOYSA-N 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000010706 fatty liver disease Diseases 0.000 claims 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical group C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 claims 1
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161448533P | 2011-03-02 | 2011-03-02 | |
| US201161448527P | 2011-03-02 | 2011-03-02 | |
| US61/448,533 | 2011-03-02 | ||
| US61/448,527 | 2011-03-02 | ||
| US201161449009P | 2011-03-03 | 2011-03-03 | |
| US61/449,009 | 2011-03-03 | ||
| PCT/US2012/027423 WO2012119046A2 (en) | 2011-03-02 | 2012-03-02 | Heterocyclic compounds for the inhibition of pask |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014506933A JP2014506933A (ja) | 2014-03-20 |
| JP2014506933A5 true JP2014506933A5 (enExample) | 2015-04-16 |
| JP6139415B2 JP6139415B2 (ja) | 2017-05-31 |
Family
ID=46758511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013556883A Expired - Fee Related JP6139415B2 (ja) | 2011-03-02 | 2012-03-02 | Ｐａｓｋの阻害のための複素環化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8912188B2 (enExample) |
| EP (1) | EP2681207B1 (enExample) |
| JP (1) | JP6139415B2 (enExample) |
| CN (1) | CN103459382B (enExample) |
| AU (1) | AU2012223232B2 (enExample) |
| BR (1) | BR112013022147A2 (enExample) |
| CA (1) | CA2828349C (enExample) |
| WO (1) | WO2012119046A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA021275B9 (ru) | 2009-09-03 | 2015-08-31 | Байоэнердженикс | Гетероциклические соединения, содержащая их фармацевтическая композиция и их применение для лечения pask-опосредованного заболевания |
| AU2014214326B2 (en) * | 2013-02-07 | 2018-07-05 | Prexton Therapeutics Sa | Substituted quinoxaline derivatives and their use as positive allosteric modulators of mGluR4 |
| WO2015059088A1 (de) | 2013-10-23 | 2015-04-30 | Bayer Cropscience Ag | Substituierte chinoxalin-derivate als schädlingsbekämpfungsmittel |
| TW201625578A (zh) | 2014-04-18 | 2016-07-16 | 千禧製藥公司 | 喹啉化合物及其用途 |
| CA2974078A1 (en) | 2015-01-20 | 2016-07-28 | Millennium Pharmaceuticals, Inc. | Quinazoline and quinoline compounds and uses thereof |
| EP3395803A1 (en) | 2017-04-28 | 2018-10-31 | Institut Pasteur | Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins |
| CN107652278A (zh) * | 2017-08-09 | 2018-02-02 | 江苏工程职业技术学院 | 一种依帕列净的合成工艺 |
| CN112062687B (zh) * | 2020-09-02 | 2023-11-21 | 上海信谊万象药业股份有限公司 | 一种盐酸阿扎司琼中间体3-氨基-5-氯-2-羟基苯甲酸甲酯的合成方法 |
| CN115197155B (zh) * | 2022-07-25 | 2023-10-24 | 宝鸡文理学院 | 一种2-喹喔啉磺酸酯类化合物及其合成方法 |
| TWI899933B (zh) | 2023-04-06 | 2025-10-01 | 美商輝瑞大藥廠 | 經取代吲唑丙酸衍生化合物及其用途 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH419399A (de) | 1962-07-18 | 1966-08-31 | Ciba Geigy | Verfahren zur Herstellung neuer Küpenfarbstoffe |
| HUT64023A (en) | 1991-03-22 | 1993-11-29 | Sandoz Ag | Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds |
| US6331555B1 (en) | 1995-06-01 | 2001-12-18 | University Of California | Treatment of platelet derived growth factor related disorders such as cancers |
| AU1918299A (en) * | 1998-02-23 | 1999-09-06 | Warner-Lambert Company | Substituted quinoxaline derivatives as interleukin-8 receptor antagonists |
| CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| JP2002534512A (ja) * | 1999-01-15 | 2002-10-15 | ノボ ノルディスク アクティーゼルスカブ | 非ペプチドｇｌｐ−１アゴニスト |
| DE10013318A1 (de) | 2000-03-17 | 2001-09-20 | Merck Patent Gmbh | Formulierung enthaltend Chinoxalinderivate |
| FR2816940A1 (fr) | 2000-11-23 | 2002-05-24 | Lipha | Derives de 4-(biphenylcarbonylamino)-piperidine, compositions les contenant et leur utilisation |
| US6319679B1 (en) | 2001-01-26 | 2001-11-20 | Board Of Regents, The University Of Texas System | PAS kinase |
| US7189724B2 (en) | 2003-04-15 | 2007-03-13 | Valeant Research And Development | Quinoxaline derivatives having antiviral activity |
| WO2005007099A2 (en) | 2003-07-10 | 2005-01-27 | Imclone Systems Incorporated | Pkb inhibitors as anti-tumor agents |
| JP2008527002A (ja) | 2005-01-13 | 2008-07-24 | サートリス ファーマシューティカルズ， インコーポレイテッド | 神経変性障害および血液凝固障害を予防および処置するための新規組成物 |
| US20060276416A1 (en) | 2005-01-20 | 2006-12-07 | Sirtris Pharmaceuticals, Inc. | Methods and compositions for treating flushing and drug induced weight gain |
| AU2006216998B2 (en) | 2005-02-14 | 2010-12-23 | Merck Sharp & Dohme Corp. | Inhibitors of Akt activity |
| WO2006138418A2 (en) | 2005-06-14 | 2006-12-28 | President And Fellows Of Harvard College | Improvement of cognitive performance with sirtuin activators |
| NZ565749A (en) * | 2005-08-26 | 2010-12-24 | Serono Lab | Pyrazine derivatives and use as PI3K inhibitors |
| WO2007146747A2 (en) | 2006-06-08 | 2007-12-21 | University Of Utah Research Foundation | Pas kinase regulates energy homeostasis |
| JP2012517448A (ja) | 2009-02-11 | 2012-08-02 | リアクション バイオロジー コープ． | 選択的キナーゼ阻害剤 |
| BRPI1009287A2 (pt) * | 2009-03-05 | 2019-09-24 | Astellas Pharma Inc | composto de quinoxalina |
| FI2440546T3 (fi) | 2009-06-12 | 2023-03-30 | Abivax | Ennenaikaisen vanhenemisen ja erityisesti progerian hoitamiseen hyödyllisiä yhdisteitä |
| EA021275B9 (ru) * | 2009-09-03 | 2015-08-31 | Байоэнердженикс | Гетероциклические соединения, содержащая их фармацевтическая композиция и их применение для лечения pask-опосредованного заболевания |
| ES2635030T3 (es) * | 2010-12-23 | 2017-10-02 | Merck Sharp & Dohme Corp. | Quinoxalinas y aza-quinoxalinas como moduladores del receptor CRTH2 |
| KR101858292B1 (ko) * | 2011-01-05 | 2018-05-15 | 바이오에너제닉스 | Ｐａｓｋ 억제용 헤테로시클릭 화합물 |
| US8916561B2 (en) * | 2011-03-02 | 2014-12-23 | Bioenergenix, Llc | Substituted quinoxaline compounds for the inhibition of PASK |
-
2012
- 2012-03-02 EP EP12751925.4A patent/EP2681207B1/en not_active Not-in-force
- 2012-03-02 CN CN201280016906.1A patent/CN103459382B/zh not_active Expired - Fee Related
- 2012-03-02 BR BR112013022147A patent/BR112013022147A2/pt not_active Application Discontinuation
- 2012-03-02 JP JP2013556883A patent/JP6139415B2/ja not_active Expired - Fee Related
- 2012-03-02 AU AU2012223232A patent/AU2012223232B2/en not_active Ceased
- 2012-03-02 CA CA2828349A patent/CA2828349C/en active Active
- 2012-03-02 WO PCT/US2012/027423 patent/WO2012119046A2/en not_active Ceased
- 2012-03-02 US US13/410,650 patent/US8912188B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11690911B2 (en) | Combination of ATR kinase inhibitors and PD-1/PD-L1 inhibitors | |
| CN103119031B (zh) | 取代酰胺化合物 | |
| CN111936503A (zh) | 噁嗪单酰甘油脂肪酶(magl)抑制剂 | |
| JP2021533093A (ja) | モノアシルグリセロールリパーゼ阻害剤としての新規複素環化合物 | |
| TW200400958A (en) | Nitrogenous heterocyclic compound and pharmaceuticals thereof | |
| KR20170094263A (ko) | Ｎａｄｐｈ 옥시다제 억제제인 아미도 티아디아졸 유도체 | |
| JP6436999B2 (ja) | オキシインドール誘導体、その製造およびａｍｐｋ関連疾患の処置におけるその治療的使用 | |
| TWI629276B (zh) | 咪唑并嗒化合物 | |
| TWI620749B (zh) | 作爲ｐｉ３激酶調節劑的芳雜環化合物及其使用方法和用途 | |
| TW201718597A (zh) | Ｈｐｋ１抑制劑及其使用方法 | |
| TW201333012A (zh) | 咪唑并吡咯啶酮化合物 | |
| KR20080000622A (ko) | 신규한 옥사디아졸 유도체 및 이의 의학적 용도 | |
| JP2016534023A5 (enExample) | ||
| CA2436739A1 (en) | Combination agent | |
| KR20170055531A (ko) | 에스지씨 자극제 | |
| CA3054247A1 (en) | Combination of atr kinase inhibitors with parp inhibitors | |
| CN104411707A (zh) | 取代的苯基咪唑并吡唑及其用途 | |
| JP2014506933A (ja) | Ｐａｓｋの阻害のための複素環化合物 | |
| JP7482324B2 (ja) | 新規なジアシルグリセリドｏ－アシルトランスフェラーゼ２阻害剤としてのオキシインドール誘導体の製造 | |
| JP2010531322A (ja) | アントラニルアミドピリジンウレア及びベンズアミド誘導体の相乗組合せ | |
| JP2017527601A (ja) | 線維症を処置するための方法及び医薬組成物 | |
| RU2016129189A (ru) | Производные 3-(5-хлор-2-оксобензо[d]оксазол-3(2н)-ил)пропановой кислоты в качестве кмо ингибиторов | |
| JP7604636B2 (ja) | 新規なジアシルグリセリドｏ－アシルトランスフェラーゼ２阻害剤としてのベンゾイミダゾロン誘導体の製造 | |
| TW202132285A (zh) | 經取代異吲哚啉基2,2’-聯嘧啶基化合物、其類似物及使用其之方法 | |
| JP2024501520A (ja) | 新規ジアシルグリセリドｏ－アシルトランスフェラーゼ２阻害薬としてのテトラヒドロインダゾール誘導体の調製 |